Growing demand for sophisticated and personalized treatment options to cure liver metastasis is expected to boost the market.Rockville, MD, Dec. 10, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a ...
News Medical on MSN12d
Extracellular vesicle DNA regulates immune responses and suppresses liver metastasisThe study highlights how EV-DNA packaging influences immune responses and its promise as a biomarker for assessing colorectal ...
Hosted on MSN13d
Delcath to trial Hepzato drug device combo in colorectal cancerThe company will evaluate the Hepzato kit as a combination therapy with the standard of care in patients with liver-dominant ...
MCCLEAN, VA, UNITED STATES, December 16, 2024 /EINPresswire / -- Perthera, the leader in AI-driven Precision Oncology Decision Support, has unveile ...
Contrary to expectations, higher levels of this EV-DNA reduced liver metastasis risks in pancreatic and colorectal cancers.
Patients with heavily pretreated microsatellite stable metastatic colorectal cancer (CRC) had survival benefits after using ...
7d
Data from the ongoing Phase 2 of EO4010 demonstrate tumor target specific immune responses and objective tumor responses, including in liver ...
About Zetagen Therapeutics Founded in 2015, Zetagen Therapeutics is a private, clinical-stage, biopharmaceutical company ...
On the morning of (UTC-6), at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS), RemeGen Co. Ltd. ("RemeGen") (9995.HK, 688331.SH) ...
On the morning of December 12, 2024 (UTC-6), at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback